Cytomegalovirus Infection in High-Risk Bone Marrow Transplant Patients: Best Practices and Emerging Strategies for Prevention

In this comprehensive program — which includes a video module, Capsule Summaries and an expert analysis of key studies presented at the recent ASH and BMT Tandem meetings, and downloadable slidesets — expert faculty review current evidence surrounding risk, prophylaxis, and treatment of CMV infection in patients undergoing bone marrow transplantation.
Roy F. Chemaly, MD
Guenther Koehne, MD, PhD
Genovefa A. Papanicolaou, MD

Module

In this Expert Analysis, Roy F. Chemaly, MD, and Guenther Koehne, MD, PhD, discuss key studies presented at the recent Hematology and BMT Tandem meetings on managing CMV infection in patients undergoing bone marrow transplantation.

Roy F. Chemaly, MD Guenther Koehne, MD, PhD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: April 21, 2017 Expired: April 20, 2018

Video Module

In this interactive, CME-certified video module, Guenther Koehne, MD, PhD, and Genovefa A. Papanicolaou, MD, provide expert perspectives on current and emerging strategies for managing CMV infection in patients undergoing bone marrow transplantation.

Guenther Koehne, MD, PhD Genovefa A. Papanicolaou, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: October 28, 2016 Expired: October 27, 2017

Downloadable Slideset

In this downloadable slideset, Guenther Koehne, MD, PhD, and Genovefa A. Papanicolaou, MD, review current and emerging strategies for managing CMV infection in patients undergoing bone marrow transplant.

Released: October 28, 2016

Conference Program

In multivariate analysis, CMV reactivation predicted by steroid use, CMV reactivation protection by high T-cell response to CMV-specific antigen pp65.

Released: March 6, 2017

Six-month survival significantly improved in patients with complete or partial virologic response vs stable or progressive disease.

Released: March 6, 2017

Letermovir prophylaxis also associated with lower all-cause mortality through post-HSCT Week 24 vs placebo.

Released: March 6, 2017

In this downloadable slideset, expert faculty members Roy F. Chemaly, MD, and Guenther Koehne, MD, PhD, review key studies presented at the Hematology 2016 and 2017 BMT Tandem meetings on managing cytomegalovirus infection in the post–bone marrow transplant setting.

Released: March 14, 2017

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?